Tengjun Biotechnology Corp.
Consumer Staples · Beverages · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $150.1M | — | $290 | — | — | — |
| Operating income | $16.1M | −$738,234 | −$666,445 | −$39,493 | −$29,898 | −$32,486 |
| Net income | $11.3M | −$747,525 | −$690,886 | −$59,865 | −$47,806 | −$48,231 |
| Total assets | $58.6M | $14.0M | $13.0M | $4,299 | $4,000 | $3,333 |
| Total liabilities | $43.7M | $16.3M | $14.2M | $283,939 | $249,147 | $218,582 |
| Equity | $14.5M | −$2.2M | −$1.2M | −$279,640 | −$245,147 | −$215,249 |
| EPS (diluted) | — | $20294447.00 | $19285714.00 | — | — | — |
| Shares out. | 65.3M | 45.8M | 43.2M | 38.1M | 38.1M | 37.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- 10.7%
- Net margin
- 7.6%
- Return on equity
- 78.5%
- Return on assets
- 19.4%
- Return on capital (ROCE)
- 107.3%
- Liabilities / assets
- 74.5%
- Debt / equity
- 3.02×
- Book value / share
- $0.22
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 3.42safe
- Accruals / assets
- 17.1%high accruals
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- High accruals — earnings-quality risk
- Operating margin is positive
- Strong return on equity (>15%)
- Positive operating cash flow
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 10, 2023
- NT 10-Qmissed a reporting deadline ↗May 10, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2015
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2014
- NT 10-Qmissed a reporting deadline ↗May 16, 2014
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Director / officer changeNov 17, 2023
- Changed auditorOct 10, 2023
- Director / officer changeSep 29, 2023
- Prior financials not reliable (restatement) · Director / officer changeAug 14, 2023
- Director / officer changeAug 7, 2023
- Other material eventMay 8, 2023
- Changed auditorMar 24, 2023
- Other material eventJan 10, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- UPLOADFeb 15, 2024
- UPLOADJan 25, 2024
- 15-15DFORM 15-15DNov 20, 2023
- 8-KCURRENT REPORTNov 17, 2023
- 8-KCURRENT REPORTOct 10, 2023
- UPLOADOct 5, 2023
- 8-KCURRENT REPORTSep 29, 2023
- CORRESPSep 21, 2023
- 8-K/AAMENDMENT NO. 2 TO FORM 8-KSep 21, 2023
- UPLOADSep 7, 2023
- CORRESPSep 5, 2023
- 8-K/AAMENDMENT NO. 1 TO FORM 8-KSep 5, 2023
- UPLOADAug 21, 2023
- 10-QQUARTERLY REPORTAug 15, 2023
- CORRESPAug 14, 2023